跳至主要内容
临床试验/NCT01845974
NCT01845974终止不适用

Atrial Pressure Electrophysiology Pilot Study: Comparison of High vs. Low Flow Catheters During Radiofrequency Catheter Ablation (RFCA) for Atrial Fibrillation (AF).

Wake Forest University Health Sciences2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2013年5月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
13
试验地点
2
主要终点
Number of Participants With Hemodynamic, Electrolyte, and Electrophysiologic Derangements

研究概览

简要总结

This study examined data elements of hemodynamic, electrophysiologic and electrolyte trends comparing 2 different types of catheters used during a procedure to treat medication resistant atrial fibrillation-radiofrequency catheter ablation. A high flow catheter delivers a high volume of saline during the procedure. The low flow catheter delivers a low volume of saline during the procedure. The patient will be consented and randomized to one of the 2 groups using a computer generated randomization chart. Those that are put in the low flow catheter group will be considered the experimental group. All data will be collected before and after the procedure and each patient will act as their own control within each group.

详细描述

Final report

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Drug resistant paroxysmal AF
  • ≥ 18 years old

排除标准

  • Left atrial thrombus on TEE
  • Patients unable to provide informed consent

研究组 & 干预措施

Low Flow Catheter

Experimental

The experimental group will receive the low flow catheter (ThermoCool® SF NAV Catheter) All data will be collected pre and post procedure therefore patients will act as their own control within each therapeutic group.

干预措施: ThermoCool® SF NAV Catheter (Device)

High Flow Catheter

Active Comparator

The control group will receive the higher flow catheter (ThermoCool® catheter). All data will be collected pre and post procedure therefore patients will act as their own control within each therapeutic group.

干预措施: ThermoCool® catheter (Device)

结局指标

主要结局

Number of Participants With Hemodynamic, Electrolyte, and Electrophysiologic Derangements

时间窗: Observation period is up to the 24 hours post procedure

The objective of this pilot study is to investigate the use of a lower flow catheter (ThermoCool® SF NAV Catheter, Biosense Webster, Inc. Diamond Bar, CA, eluting 8-15ml/minute during RF lesion delivery) vs. a higher flow catheter (ThermoCool® catheter, same manufacturer, eluting 17-30 ml/minute), Outcomes are measured by number of Participants with Hemodynamic, Electrolyte, and Electrophysiologic Derangements, is reported. This was measured as participants requiring electrolyte replacement, if the BP dropped below 100 mm in CICU or if participants sustained atrial tachyarrhythmias

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验